This PDF is the current document as it appeared on Public Inspection on 05/13/2013 at 08:45 am.
In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee:
Times and Dates: 9:00 a.m.-5:00 p.m., June 5, 2013; 9:00 a.m.-12:00 p.m., June 6, 2013.
Place: Centers for Disease Control and Prevention (CDC), Global Communications Center, Bldg 19, Auditorium B3, 1600 Clifton Rd., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.
Matters To Be Discussed: The agenda will include updates on CDC's activities for healthcare associated infections (HAI), an update on draft CDC guideline for the prevention of surgical site infections and guideline for infection prevention in healthcare personnel. Also to be discussed are updates on National Healthcare Safety Network (NHSN) surveillance activities including definitions for catheter-associated urinary tract infections.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-4045. Email: email@example.com.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).
[FR Doc. 2013-11330 Filed 5-13-13; 8:45 am]
BILLING CODE 4163-18-P